ArticleCase reports in hepatology2025
Hemophagocytic Lymphohistiocytosis Complicating a Case of Drug-Induced Liver Injury Precipitated by Cephalexin: A Rare Consequence of Commonly Prescribed Medications.
Article in Case reports in hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced liver injury (DILI) is a relatively rare clinical syndrome that accounts for a significant proportion of acute liver failure progressing to transplant in the United States. Some drugs such as acetaminophen are classically associated with a predictable pattern of DILI that can often be reversed with prompt administration of guideline-directed therapeutics. In other cases, commonly prescribed medications can lead to an unpredictable variant of DILI in certain vulnerable populations for which few guidelines on management exist, likely in part due to the heterogeneity of precipitating toxins. We report a case of idiosyncratic DILI caused by cephalexin that progressed to fulminant hemophagocytic lymphohistiocytosis (HLH) in a young and previously healthy patient, alongside our experiences with therapeutic management and outcomes guided by a multidisciplinary team.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.